Scarica l'app Stockscreener
13.92
0.80%
0.11
Dopo l'orario di chiusura:
13.94
0.02
+0.14%
Precedente Chiudi:
$13.81
Aprire:
$13.82
Volume 24 ore:
99,732
Relative Volume:
0.58
Capitalizzazione di mercato:
$164.62M
Reddito:
$42.16M
Utile/perdita netta:
$-14.38M
Rapporto P/E:
-7.7765
EPS:
-1.79
Flusso di cassa netto:
$-9.90M
1 W Prestazione:
-0.29%
1M Prestazione:
+2.13%
6M Prestazione:
+88.62%
1 anno Prestazione:
+264.40%
Intervallo 1D:
$13.80
$13.94
Intervallo di 1 settimana:
$13.68
$14.00
Portata 52W:
$3.47
$17.31
Lensar Inc Stock (LNSR) Company Profile
Nome
Lensar Inc
Settore
Industria
Telefono
888-536-7271
Indirizzo
2800 DISCOVERY DRIVE, ORLANDO
Confronta LNSR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
13.92 | 164.62M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-02-24 | Iniziato | SVB Leerink | Outperform |
Lensar Inc Borsa (LNSR) Ultime notizie
LENSAR revenue up 34% to USD 14.2 million in Q1 2025 - Medical Buyer
LENSAR Reports Strong Q1 2025 Growth Amid Merger Plans - TipRanks
LENSAR Inc reports results for the quarter ended March 31Earnings Summary - TradingView
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
LENSAR, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
LENSAR earnings missed by $2.17, revenue fell short of estimates - Investing.com
LNSR Achieves Strong Q1 Revenue Growth in 2025 | LNSR Stock News - GuruFocus
LENSAR Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimates at $14.2M, EPS Falls Short at ($2.32) - GuruFocus
LENSAR Reports First Quarter 2025 Results and Provides Business Update - TradingView
LENSAR Reports First Quarter 2025 Results and Provides Business Update | LNSR Stock News - GuruFocus
LENSAR, Inc. Reports 34% Revenue Growth and 14 ALLY Systems Placed in Q1 2025 - Nasdaq
(LNSR) Technical Data - news.stocktradersdaily.com
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance | LIVN Stock News - GuruFocus
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - Stock Titan
LENSAR Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Geode Capital Management LLC Buys 5,627 Shares of LENSAR, Inc. (NASDAQ:LNSR) - Defense World
LENSAR (LNSR) Projected to Post Earnings on Thursday - Defense World
LENSAR, Inc. (NASDAQ:LNSR) Short Interest Up 92.9% in April - Defense World
Halper Sadeh LLP, AZEK Company Inc., LENSAR, Inc., Dun & Bradstreet Holdings, Inc. - Olean Times Herald
LENSAR: It Is All About The Contingent Value Right Now (NASDAQ:LNSR) - Seeking Alpha
LENSAR (NASDAQ:LNSR) Stock Price Up 0.1% – Still a Buy? - Defense World
How to Take Advantage of moves in (LNSR) - news.stocktradersdaily.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (NasdaqLNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSEDNB), Global Blue Group Holding AG (N - TradingView
Is LENSAR (LNSR) a Deeply Undervalued Stock? - Insider Monkey
Trading (LNSR) With Integrated Risk Controls - news.stocktradersdaily.com
Taxation With Representation: Norton Rose, Latham, Ashurst - Law360
Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock? - Yahoo Finance
Alcon Inc’s Acquisition of LENSAR Inc - Global Legal Chronicle
Related Content: Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
Alcon to buy Lensar in deal worth up to $430M - The Business Journals
Alcon to Acquire LENSAR - Photonics Spectra
Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
ALC Stock Rises Following the Merger Agreement With LENSAR - MSN
Alcon signs merger agreement to acquire Lensar - MSN
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc.LNSR - Business Wire
Bernstein maintains Alcon Outperform rating, $110.50 target By Investing.com - Investing.com UK
Alcon lines up Lensar deal to expand laser cataract surgery options - Optics.org
BTIG Research Downgrades LENSAR to Neutral From Buy - MarketScreener
Alcon agrees to purchase LENSAR - Ophthalmology Times
Switzerland: Alcon agrees acquisition of Lensar for up to US$430m - Investors in Healthcare
LENSAR’s (LNSR) “Hold” Rating Reaffirmed at Lake Street Capital - Defense World
Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million - VisionMonday.com
BTIG cuts LENSAR stock rating post Alcon acquisition deal - Investing.com India
BTIG cuts LENSAR stock rating post Alcon acquisition deal By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc.LNSR - The Malaysian Reserve
Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon - Latham & Watkins LLP
Alcon to Acquire LENSAR in $430M Deal - USA Herald
Alcon to acquire Lensar for up to $430M - BioWorld MedTech
Norton Rose, Latham Steer Alcon's $430M Lensar Buy - Law360
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Lensar Inc Azioni (LNSR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):